Menu
1 min read · estimated
APPROVED USE
What FDA approved
With trastuzumab and fluoropyrimidine- plus platinum-containing chemotherapy as initial treatment for adults with locally advanced unresectable or metastatic HER2-positive gastric or GEJ adenocarcinoma and PD-L1 CPS of at least 1.
LAMPGEN ANALYSIS
Why it matters
KEYNOTE-811 supported traditional approval for the PD-L1-positive subgroup after an earlier accelerated approval.
What research teams should watch
Organize HER2 and PD-L1 testing together so first-line regimen decisions use both results before treatment starts.
PRIMARY RECORDS